Association of angiogenesis in lymph node metastases with outcome of breast cancer

Journal of the National Cancer Institute

Volumn 92, Issue 6, 2000, Pages 486-492

  Guidi, Anthony J ^a   Berry, Donald A ^b   Broadwater, Gloria ^c   Perloff, Marjorie ^d   Norton, Larry ^e   Barcos, Maurice P ^f   Hayes, Daniel F ^g  

^a NORTH SHORE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Cancer Leukemia Grp B Stat Ctr   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0034654130     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.6.486     Document Type: Article

References (30)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990;1032: 89-118.
3. Weidner N, Semple P, Welch W, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
4. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
5. Horak E, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by plalelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340: 1120-4.
6. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E, Meli S, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
7. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12: 454-66.
8. Hayes DF. Angiogenesis and breast cancer In: Shapiro CL, Henderson IC, editors. Hematology/Oncology clinics of North America. Philadelphia (PA): Saunders: 1994. p. 51-71.
9. Perloff M, Norton L, Korzun A, Wood W, Carey R, Gottlieb A, et al. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-crossresistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol 1996;14:1589-98.
10. Jacobs T, Prioleau J, Stillman I, Schnitt S. Loss of tumor marker immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 1996;88:1054-9.
11. Guidi A, Schnitt S. Angiogenesis in preinvasive lesions of the breast. Breast 1996;2:364-9.
12. Guidi AJ, Fischer L, Harris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-9.
13. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994;21:441-3.
14. Axelsson K, Ljung BM, Moore D, Thor A, Chew K, Edgerton S, et al. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst 1995;87: 997-1008.
15. Costello P, McCann A, Carney D, Dervan P. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum Pathol 1995;26:1181-4.
16. Goulding H, Abdul Rashid N, Robertson J, Bell J, Elston C, Blamey R, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol 1995;26:1196-200.
17. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-56.
18. Miliaras D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance? Histopathology 1995;26:165-9.
19. Hillen HF, Hak LE, Joosten-Achjanie SR, Arends JW. Microvessel density in unknown primary tumors. Int J Cancer 1997;74:81-5.
20. Mooteri S, Rubin D, Leurgans S, Jakate S, Drab E, Saclarides T. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 1996;39:1073-80.
21. Brown LF, Berse B, Jackman R, Tognazzi K, Guidi A, Dvorak H, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
22. Guidi AJ, Schitt S, Fischer L, Tognazzi K, Harris J, Dvorak H, et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 1997;80:1945-53.
23. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045-9.
24. Toi M, Kundo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T. et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 1996;77:1101-6.
25. Anan K, Morisaki T, Katano M, Ikubo A, Kitsuki H, Uchiyama A, et al. Vascular endothelial growth factor and platelet derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996; 119:333-9.
26. Hayes DF, Bast R, Desch CE, Fritsche H, Kemeny NE, Jessup J, et al. A tumor marker utility grading system (TMUGS): a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 1996;88:1456-66.
27. Folkman J. What is the role of angiogenesis in metastasis from cutaneous melanoma? Eur J Cancer Clin Oncol 1987;23:361-3.
28. Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
29. Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993;85: 1206-19.
30. Hayes DF, Trock B, Harris A. Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful? Breast Cancer Res Treat 1998;52:305-19.